Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 19 September 2027
- Last conf. stmt
- 5 September 2026
Trucs Therapeutics Limited
- Incorporated
- 4 January 2019 (7 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Owned by
- Accounts type
- Small
- Region
- South East
- Address
- 2 Minton PlaceVictoria RoadBicesterOX26 6QB
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 1 active
Officer details are public data from the Companies House register.
Director · Appointed 14 November 2025
British
Born March 1980 (46)
Officer history (7 former)
14 November 2025
Resigned Bertrand, William Charles as Director
14 November 2025
Resigned Rawcliffe, Adrian George as Director
14 November 2025
30 September 2025
Resigned Henry, Margaret as Secretary
30 September 2025
Appointed Bertrand, William Charles as Director
30 September 2025
Appointed Rawcliffe, Adrian George as Director
30 September 2025
Resigned Henry, Margaret as Director
9 September 2025
Resigned Wood, Gavin as Director
10 July 2023
Appointed Henry, Margaret as Secretary
10 July 2023
Appointed Henry, Margaret as Director
10 July 2023
Appointed Wood, Gavin as Director
10 July 2023
Resigned Siegel, Margaret as Secretary
10 July 2023
Resigned Menzel, Garry Edward as Director
4 January 2019
Appointed Siegel, Margaret as Secretary
4 January 2019
Appointed Menzel, Garry Edward as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 1 June 2023
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 09338148
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Adaptimmune Limited Owns 75–100% of shares
Trucs Therapeutics Limited This company Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 30 June 2025, are filed but not read yet. See them on Companies House
- Cash
- £328,226
- Current Ratio
- 85.6x
Trend
Shareholder Funds
Balance sheet detail
| 2024 | 2022 | |
|---|---|---|
| Fixed Assets | £0 | |
| Current Assets | £2,239,906 | £2,968,239 |
| Debtors | £1,911,680 | £2,655,534 |
| Cash | £328,226 | £312,705 |
| Creditors (< 1 year) | £26,178 | £716,818 |
| Net Current Assets | £2,213,728 | £2,251,421 |
| Net Assets | £2,251,421 | |
| Shareholder Funds | £2,213,728 | £2,251,421 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 15 September 2026 | Confirmation statement with no updates | 5 September 2026 |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →